{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:47:38Z","timestamp":1794854858617,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21-AG064348"],"award-info":[{"award-number":["R21-AG064348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NIA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Non-invasive diffusion-weighted imaging (DWI) to assess brain microstructural changes via cortical mean diffusivity (cMD) has been shown to be cross-sectionally associated with tau in cognitively normal older adults, suggesting that it might be an early marker of neuronal injury. Here, we investigated how regional cortical microstructural changes measured by cMD are related to the longitudinal accumulation of regional tau as well as to episodic memory decline in cognitively normal individuals harboring amyloid pathology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>122 cognitively normal participants from the Harvard Aging Brain Study underwent DWI, T1w-MRI, amyloid and tau PET imaging, and Logical Memory Delayed Recall (LMDR) assessments. We assessed whether the interaction of baseline amyloid status and cMD (in entorhinal and inferior-temporal cortices) was associated with longitudinal regional tau accumulation and with longitudinal LMDR using separate linear mixed-effects models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We find a significant interaction effect of the amyloid status and baseline cMD in predicting longitudinal tau in the entorhinal cortex (<jats:italic>p<\/jats:italic>\u2009=\u20090.044) but not the inferior temporal lobe, such that greater baseline cMD values predicts the accumulation of entorhinal tau in amyloid-positive participants. Moreover, we find a significant interaction effect of the amyloid status and baseline cMD in the entorhinal cortex (but not inferior temporal cMD) in predicting longitudinal LMDR (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), such that baseline entorhinal cMD predicts the episodic memory decline in amyloid-positive participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The combination of amyloidosis and elevated cMD in the entorhinal cortex may help identify individuals at short-term risk of tau accumulation and Alzheimer\u2019s Disease-related episodic memory decline, suggesting utility in clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.1038\/s43856-023-00324-7","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T11:01:53Z","timestamp":1690887713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-8456","authenticated-orcid":false,"given":"Geoffroy","family":"Gagliardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6639-8141","authenticated-orcid":false,"given":"Elena","family":"Rodriguez-Vieitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Montal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sepulcre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-0178","authenticated-orcid":false,"given":"Ibai","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-2212","authenticated-orcid":false,"given":"Cristina","family":"Lois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Properzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn V.","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1535-6133","authenticated-orcid":false,"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9425-1059","authenticated-orcid":false,"given":"Patrizia","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"324_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"324_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois, B. et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 20, 484\u2013496 (2021).","journal-title":"Lancet Neurol."},{"key":"324_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois, B. et al. Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 12, 292\u2013323 (2016).","journal-title":"Alzheimers Dement."},{"key":"324_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia. JAMA 313, 1924 (2015).","journal-title":"JAMA"},{"key":"324_CR5","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/jama.2015.4669","volume":"313","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele, R. et al. Prevalence of amyloid PET positivity in dementia syndromes. JAMA 313, 1939 (2015).","journal-title":"JAMA"},{"key":"324_CR6","doi-asserted-by":"publisher","first-page":"eaaz2387","DOI":"10.1126\/sciadv.aaz2387","volume":"6","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren, N. et al. A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease. Sci. Adv. 6, eaaz2387 (2020).","journal-title":"Sci. Adv."},{"key":"324_CR7","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin, A. et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain 140, 3286\u20133300 (2017).","journal-title":"Brain"},{"key":"324_CR8","first-page":"1109","volume":"2","author":"D Le Bihan","year":"1985","unstructured":"Le Bihan, D. & Breton, \u00c9. Imagerie de self-diffusion in vivo par r\u00e9sonance magn\u00e9tique nucl\u00e9aire. Comptes Rendus Acad\u00e9mie Sci. 2, 1109\u20131112 (1985).","journal-title":"Comptes Rendus Acad\u00e9mie Sci."},{"key":"324_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jalz.2017.09.013","volume":"14","author":"V Montal","year":"2018","unstructured":"Montal, V. et al. Cortical microstructural changes along the Alzheimer\u2019s disease continuum. Alzheimers Dement. 14, 340\u2013351 (2018).","journal-title":"Alzheimers Dement."},{"key":"324_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/alz.12224","volume":"17","author":"V Montal","year":"2021","unstructured":"Montal, V. et al. Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer\u2019s disease. Alzheimers Dement. 17, 618\u2013628 (2021).","journal-title":"Alzheimers Dement."},{"key":"324_CR11","doi-asserted-by":"publisher","first-page":"e2026","DOI":"10.1212\/WNL.0000000000009405","volume":"94","author":"E Vilaplana","year":"2020","unstructured":"Vilaplana, E. et al. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease. Neurology 94, e2026\u2013e2036 (2020).","journal-title":"Neurology"},{"key":"324_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","volume":"70","author":"J Fortea","year":"2011","unstructured":"Fortea, J. et al. Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1-42 values have thicker cortex in alzheimer\u2019s disease vulnerable areas. Biol. Psychiatry 70, 183\u2013190 (2011).","journal-title":"Biol. Psychiatry"},{"key":"324_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.24186","volume":"76","author":"J Fortea","year":"2014","unstructured":"Fortea, J., Vilaplana, E., Alcolea, D., Blesa, R. & Lle, A. Cerebrospinal fluid b -amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Ann. Neurol. 76, 223\u2013230 (2014).","journal-title":"Ann. Neurol."},{"key":"324_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jalz.2016.08.010","volume":"13","author":"J Pegueroles","year":"2017","unstructured":"Pegueroles, J. et al. Longitudinal brain structural changes in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 13, 499\u2013509 (2017).","journal-title":"Alzheimers Dement."},{"key":"324_CR15","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1038\/s41380-021-01290-z","volume":"26","author":"E Rodriguez-Vieitez","year":"2021","unstructured":"Rodriguez-Vieitez, E. et al. Association of cortical microstructure with amyloid-\u03b2 and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. Mol. Psychiatry 26, 7813\u20137822 (2021).","journal-title":"Mol. Psychiatry"},{"key":"324_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/JAD-130080","volume":"35","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Altered default mode network connectivity in older adults with cognitive complaints and amnestic mild cognitive impairment. J. Alzheimers Dis. 35, 751\u2013760 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"324_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/brain.2016.0438","volume":"7","author":"LE Mak","year":"2017","unstructured":"Mak, L. E. et al. The default mode network in healthy individuals: a systematic review and meta-analysis. Brain Connect. 7, 25\u201333 (2017).","journal-title":"Brain Connect."},{"key":"324_CR18","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/cercor\/bhr025","volume":"21","author":"EC Mormino","year":"2011","unstructured":"Mormino, E. C. et al. Relationships between beta-amyloid and functional connectivity in different components of the default mode network in aging. Cereb. Cortex 21, 2399\u20132407 (2011).","journal-title":"Cereb. Cortex"},{"key":"324_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","volume":"67","author":"YI Sheline","year":"2010","unstructured":"Sheline, Y. I. et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol. Psychiatry 67, 584\u2013587 (2010).","journal-title":"Biol. Psychiatry"},{"key":"324_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"H Amieva","year":"2008","unstructured":"Amieva, H. et al. Prodromal Alzheimer\u2019 s disease: successive emergence of the clinical symptoms. Ann. Neurol. 64, 492\u2013498 (2008).","journal-title":"Ann. Neurol."},{"key":"324_CR21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/brain\/awu035","volume":"137","author":"H Amieva","year":"2014","unstructured":"Amieva, H. et al. Compensatory mechanisms in higher-educated subjects with Alzheimer\u2019s disease: a study of 20 years of cognitive decline. Brain 137, 1167\u20131175 (2014).","journal-title":"Brain"},{"key":"324_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1212\/WNL.54.4.827","volume":"54","author":"E Grober","year":"2000","unstructured":"Grober, E., Lipton, R. B., Hall, C. & Crystal, H. Memory impairment on free and cued selective reminding predicts dementia. Neurology 54, 827\u2013832 (2000).","journal-title":"Neurology"},{"key":"324_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1017\/S1355617708080302","volume":"14","author":"E Grober","year":"2008","unstructured":"Grober, E. et al. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer\u2019s disease. J. Int. Neuropsychol. Soc. 14, 266\u2013278 (2008).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"324_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","volume":"80","author":"T Hedden","year":"2013","unstructured":"Hedden, T., Oh, H., Younger, A. P. & Patel, T. A. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology 80, 1341\u20131348 (2013).","journal-title":"Neurology"},{"key":"324_CR25","doi-asserted-by":"publisher","unstructured":"Spotorno, N., Strandberg, O., Vis, G., Stomrud, E. & Nilsson, M. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer\u2019s disease. Brain 36 https:\/\/doi.org\/10.1093\/brain\/awac343 (2022).","DOI":"10.1093\/brain\/awac343"},{"key":"324_CR26","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","volume":"15","author":"SC Burnham","year":"2016","unstructured":"Burnham, S. C. et al. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology: a longitudinal study. Lancet Neurol. 15, 1044\u20131053 (2016).","journal-title":"Lancet Neurol."},{"key":"324_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2017.04.004","volume":"56","author":"SE Schindler","year":"2017","unstructured":"Schindler, S. E. et al. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease. Neurobiol. Aging 56, 25\u201332 (2017).","journal-title":"Neurobiol. Aging"},{"key":"324_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"324_CR29","unstructured":"Wechsler, D. Manual for the Wechsler Memory Scale\u2014Revised. (TX: The Psychological Corporation, 1987)."},{"key":"324_CR30","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"324_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage, J. A. et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17, 37\u201349 (1982).","journal-title":"J. Psychiatr. Res."},{"key":"324_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk, W. E. et al. Imaging brain amyloid in Alzheimer\u2019s disease with pittsburgh compound-B. Ann. Neurol. 55, 306\u2013319 (2004).","journal-title":"Ann. Neurol."},{"key":"324_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"C Xia","year":"2013","unstructured":"Xia, C. et al. [18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement. 9, 666\u2013676 (2013).","journal-title":"Alzheimers Dement."},{"key":"324_CR34","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. USA. 97, 11050\u201311055 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"324_CR35","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968\u2013980 (2006).","journal-title":"NeuroImage"},{"key":"324_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuroimage.2015.03.069","volume":"144","author":"A Dagley","year":"2017","unstructured":"Dagley, A. et al. Harvard aging brain study: dataset and accessibility. NeuroImage 144, 255\u2013258 (2017).","journal-title":"NeuroImage"},{"key":"324_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson, K. A. et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol. 79, 110\u2013119 (2016).","journal-title":"Ann. Neurol."},{"key":"324_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel, J. W. et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat. Commun. 11, 2612 (2020).","journal-title":"Nat. Commun."},{"key":"324_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.arr.2017.03.002","volume":"36","author":"B Hall","year":"2017","unstructured":"Hall, B. et al. In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Ageing Res. Rev. 36, 50\u201363 (2017).","journal-title":"Ageing Res. Rev."},{"key":"324_CR40","doi-asserted-by":"publisher","first-page":"116991","DOI":"10.1016\/j.neuroimage.2020.116991","volume":"220","author":"MR Scott","year":"2020","unstructured":"Scott, M. R. et al. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults. NeuroImage 220, 116991 (2020).","journal-title":"NeuroImage"},{"key":"324_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","volume":"71","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Synergistic effect of ss-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 71, 1379\u20131385 (2014).","journal-title":"JAMA Neurol."},{"key":"324_CR42","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","volume":"82","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Amyloid and APOE \u03b54 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82, 1760\u20131767 (2014).","journal-title":"Neurology"},{"key":"324_CR43","unstructured":"Bonferroni, C. E. Teoria statistica delle classi e calcolo delle probabilit\u00e0. (Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze, 1939)."},{"key":"324_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyg.2012.00111","volume":"3","author":"AS Selya","year":"2012","unstructured":"Selya, A. S., Rose, J. S., Dierker, L. C., Hedeker, D. & Mermelstein, R. J. A practical guide to calculating Cohen\u2019s f 2, a measure of local effect size, from PROC MIXED. Front. Psychol. 3, 1\u20136 (2012).","journal-title":"Front. Psychol."},{"key":"324_CR45","unstructured":"Cohen, J., Cohen, P., West, S. G. & Aiken, L. S. Applied multiple regression\/correlation analyses for the behavioral sciences. (Lawrence Erlbaum Associates, Inc., 2003)."},{"key":"324_CR46","doi-asserted-by":"crossref","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. M. & Walker, S. C. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","DOI":"10.18637\/jss.v067.i01"},{"key":"324_CR47","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak, H., Thal, D. R., Ghebremedhin, E. & Del Tredici, K. Stages of the pathologic process in alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 70, 960\u2013969 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"324_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 280\u2013292 (2011).","journal-title":"Alzheimers Dement."},{"key":"324_CR49","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll, M. et al. PET imaging of tau deposition in the aging human brain. Neuron 89, 971\u2013982 (2016).","journal-title":"Neuron"},{"key":"324_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack, C. R. et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539\u2013547 (2016).","journal-title":"Neurology"},{"key":"324_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jalz.2016.11.005","volume":"13","author":"TA Pascoal","year":"2017","unstructured":"Pascoal, T. A. et al. Synergistic interaction between amyloid and tau predicts the progression to dementia. Alzheimers Dement. 13, 644\u2013653 (2017).","journal-title":"Alzheimers Dement."},{"key":"324_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","volume":"73","author":"RC Petersen","year":"2016","unstructured":"Petersen, R. C. et al. Association of elevated amyloid levels with cognition and biomarkers in cognitively normal people from the community. JAMA Neurol. 73, 85\u201392 (2016).","journal-title":"JAMA Neurol."},{"key":"324_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamaneurol.2017.3029","volume":"75","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. Amyloid \u03b2 deposition and suspected non-alzheimer pathophysiology and cognitive decline patterns for 12 years in oldest old participants without dementia. JAMA Neurol. 75, 88 (2018).","journal-title":"JAMA Neurol."},{"key":"324_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-\u03b2 and tau the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505 (2014).","journal-title":"JAMA Neurol."},{"key":"324_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/mp.2016.37","volume":"22","author":"TA Pascoal","year":"2017","unstructured":"Pascoal, T. A. et al. Amyloid-\u03b2 and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer\u2019s disease. Mol. Psychiatry 22, 306\u2013311 (2017).","journal-title":"Mol. Psychiatry"},{"key":"324_CR56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling, R. A. et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann. Neurol. 85, 181\u2013193 (2019).","journal-title":"Ann. Neurol."},{"key":"324_CR57","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw, B. J. et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 76, 915\u2013924 (2019).","journal-title":"JAMA Neurol."},{"key":"324_CR58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/13854046.2015.1047407","volume":"29","author":"EM Jonaitis","year":"2015","unstructured":"Jonaitis, E. M. et al. Aging, practice effects, and genetic risk in the Wisconsin registry for Alzheimer\u2019 s prevention. Clin. Neuropsychol. 29, 426\u2013441 (2015).","journal-title":"Clin. Neuropsychol."},{"key":"324_CR59","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.trci.2017.10.004","volume":"3","author":"K Papp","year":"2017","unstructured":"Papp, K., Rentz, D. M., Orlovsky, I., Sperling, R. A. & Mormino, E. C. Optimizing the preclinical Alzheimer\u2019s cognitive composite with semantic processing: the PACC5. Alzheimers Dement. Transl. Res. Clin. Interv. 3, 668\u2013677 (2017).","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"324_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuroimage.2008.11.024","volume":"45","author":"GC Schwindt","year":"2009","unstructured":"Schwindt, G. C. & Black, S. E. Functional imaging studies of episodic memory in Alzheimer\u2019s disease: a quantitative meta-analysis. NeuroImage 45, 181\u2013190 (2009).","journal-title":"NeuroImage"},{"key":"324_CR61","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.neuropsychologia.2013.01.013","volume":"51","author":"DI Hirni","year":"2013","unstructured":"Hirni, D. I., Kivisaari, S. L., Monsch, A. U. & Taylor, K. I. Distinct neuroanatomical bases of episodic and semantic memory performance in Alzheimer\u2019 s disease. Neuropsychologia 51, 930\u2013937 (2013).","journal-title":"Neuropsychologia"},{"key":"324_CR62","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele, R. et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139, 1551\u20131567 (2016).","journal-title":"Brain"},{"key":"324_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00415-008-0726-9","volume":"255","author":"U Beinhoff","year":"2008","unstructured":"Beinhoff, U., Tumani, H., Brettschneider, J., Bittner, D. & Riepe, M. W. Gender-specificities in Alzheimer\u2019s disease and mild cognitive impairment. J. Neurol. 255, 117\u2013122 (2008).","journal-title":"J. Neurol."},{"key":"324_CR64","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","volume":"14","author":"RF Buckley","year":"2018","unstructured":"Buckley, R. F. et al. Sex, amyloid, and APOE \u03b54 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: findings from three well-characterized cohorts. Alzheimers Dement. 14, 1193\u20131203 (2018).","journal-title":"Alzheimers Dement."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00324-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00324-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00324-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T06:59:34Z","timestamp":1702882774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00324-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00324-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}